Codify By AAPC
ICD-10-PCS Codes
1
3E0L05Z (INTRODUCTION OF ADHESION BARRIER INTO PLEURAL CAVITY, OPEN APPROACH)
2
3E0L304 (INTRODUCTION OF LIQUID BRACHYTHERAPY RADIOISOTOPE INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
3
3E0L305 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
4
3E0L30M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
5
3E0L317 (INTRODUCTION OF OTHER THROMBOLYTIC INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
6
3E0L328 (INTRODUCTION OF OXAZOLIDINONES INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
7
3E0L329 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
8
3E0L33Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
9
3E0L35Z (INTRODUCTION OF ADHESION BARRIER INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
10
3E0L36Z (INTRODUCTION OF NUTRITIONAL SUBSTANCE INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
11
3E0L37Z (INTRODUCTION OF ELECTROLYTIC AND WATER BALANCE SUBSTANCE INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
12
3E0L3BZ (INTRODUCTION OF ANESTHETIC AGENT INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
13
3E0L3GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
14
3E0L3HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
15
3E0L3KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
16
3E0L3NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
17
3E0L3SF (INTRODUCTION OF OTHER GAS INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
18
3E0L3TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO PLEURAL CAVITY, PERCUTANEOUS APPROACH)
19
3E0L45Z (INTRODUCTION OF ADHESION BARRIER INTO PLEURAL CAVITY, PERCUTANEOUS ENDOSCOPIC APPROACH)
20
3E0L4GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO PLEURAL CAVITY, PERCUTANEOUS ENDOSCOPIC APPROACH)
21
3E0L704 (INTRODUCTION OF LIQUID BRACHYTHERAPY RADIOISOTOPE INTO PLEURAL CAVITY, VIA NATURAL OR ARTIFICIAL OPENING)
22
3E0L705 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO PLEURAL CAVITY, VIA NATURAL OR ARTIFICIAL OPENING)
23
3E0L70M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO PLEURAL CAVITY, VIA NATURAL OR ARTIFICIAL OPENING)
24
3E0L7SF (INTRODUCTION OF OTHER GAS INTO PLEURAL CAVITY, VIA NATURAL OR ARTIFICIAL OPENING)